Company / Shareholders' Equity
HARVARD BIOSCIENCE INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$63.3M
FY2025
5-year range
$63.3M / $83.4M
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $63M in FY2025 to $95M in FY2016.
Based on SEC 10-K filings.
$63M in FY2025 with a 5-year CAGR of -5.2%.
Declined from $72M to $63M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 13.3% year-over-year.
- Peak shareholders' equity was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.3M | -13.3% |
| FY2024 | $73.1M | +1.2% |
| FY2023 | $72.2M | -13.4% |
| FY2022 | $83.4M | +8.8% |
| FY2021 | $76.7M | -7.3% |
| FY2020 | $82.7M | +0.0% |
| FY2019 | $82.7M | +2.3% |
| FY2018 | $80.9M | +12.1% |
| FY2017 | $72.2M | -24.4% |
| FY2016 | $95.5M | +1.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026